Trump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift
The move could speed research, ease tax burdens for cannabis companies and preserve federal limits on recreational use.
- On Thursday, Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana from Schedule I to Schedule III, easing research barriers and granting licensed operators federal tax deductions.
- President Donald Trump ordered his administration in December to accelerate rescheduling. Blanche stated the action was "delivering on President Trump's promise" to expand Americans' access to medical treatment options.
- The action legitimizes medical marijuana systems in 40 states, shifting away from prohibition standards dating to the Marijuana Tax Act of 1937, while non-licensed marijuana remains strictly regulated under Schedule I.
- Although the order provides tax relief, it does not legalize marijuana for recreational use. In Washington, 302 of 460 licensed stores have endorsements allowing tax-free sales to registered patients.
- More than 20 Republican senators urged the president to maintain existing standards last year, and the Justice Department plans to launch administrative hearings in June to consider broader marijuana rescheduling.
93 Articles
93 Articles
Pot firms rally after US reclassifies marijuana as less dangerous drug
Shares of cannabis firms surged on Thursday after the U.S. government moved to reclassify the Food and Drug Administration-approved and state-licensed marijuana as a less-dangerous drug.
Trump admin rewrites the rulebook on weed with reclassification — making research and banking much easier
Acting Attorney General Todd Blanche signed orders Thursday reclassifying state-legal marijuana as a less-dangerous Schedule III drug — easing research into the plant's medicinal properties after more than five decades.
US reclassifies certain marijuana products as a less-dangerous drug
The US Department of Justice is reclassifying FDA-approved and state-licensed marijuana as a less dangerous drug, Acting Attorney General Todd Blanche said on Thursday. The announcement does not legalise marijuana across the United States. In a post on X, Blanche said the Justice Department was “immediately rescheduling FDA-approved marijuana and state-licensed marijuana from Schedule I to Schedule III”. The department is also initiating an exp…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
























